Tapewire

NYSE · USD

CIM

CHIMERA INVESTMENT CORP

Export transactions ↓
Tapewire entity
4990
SEC CIK
0001409493
Parsed reports
230

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 01, 2022 Filed Jan 4, 2022 21:32 UTC
Kardis Phillip John IIChief Legal Officer
GrantCommon Stock 32,347 $0.00 $0.00
Disclosure

SEC source: 0001157523-22-000011 · form4.xml · nonDerivative · entry 1

Kardis Phillip John II · CIK 0001652530 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,747

F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · shares: The reporting person elected to defer share settlement until separation of service (such deferred share units are herein referred to as "DSUs").

F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

F4 · balance_after: Dividend equivalent rights ("DERs') issued on RSUs and DSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
January 01, 2022 Filed Jan 4, 2022 21:35 UTC
Viswanathan SubramaniamChief Financial Officer
GrantCommon Stock 24,505 $0.00 $0.00
Disclosure

SEC source: 0001157523-22-000012 · form4.xml · nonDerivative · entry 1

Viswanathan Subramaniam · CIK 0001876812 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,002

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

F3 · balance_after: The reporting person elected to defer share settlement until separation of service (such deferred share units are herein referred to as "DSUs"). Dividend equivalent rights ("DERs') issued on RSUs and DSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
December 27, 2021 Filed Dec 28, 2021 16:30 UTC
Kortman KelleyPrincipal Accounting Officer
GiftCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-001528 · form4.xml · nonDerivative · entry 1

Kortman Kelley · CIK 0001869475 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,245

F1 · price: This transaction involved a gift of securities by the Reporting Person to his adult children. Disposition price is not applicable as this transaction was a bona fide gift.

Read SEC document
December 15, 2021 Filed Dec 21, 2021 18:17 UTC
Kortman KelleyPrincipal Accounting Officer
Tax withholdingCommon Stock 1,945 $15.21 $29,583.45
Disclosure

SEC source: 0001157523-21-001515 · form4.xml · nonDerivative · entry 2

Kortman Kelley · CIK 0001869475 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,745

F3 · shares: Shares reported were withheld for payment of taxes associated with the vesting of prior grants of RSUs.tnote

Read SEC document
December 15, 2021 Filed Dec 21, 2021 18:17 UTC
Kortman KelleyPrincipal Accounting Officer
GrantCommon Stock 7,817 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-001515 · form4.xml · nonDerivative · entry 1

Kortman Kelley · CIK 0001869475 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,690

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). Each RSU has the economic equivalent of one share of Chimera common stock. The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · balance_after: Dividend equivalent rights ("DERs") issued on RSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
December 02, 2021 Filed Dec 3, 2021 17:00 UTC
Bell SandraDirector
GrantCommon Stock 3,671 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-001478 · form4.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,671

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) June 10, 2022, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
August 25, 2021 Filed Aug 25, 2021 16:33 UTC
Kortman KelleyPrincipal Accounting Officer
PurchaseSeries B Preferred Stock 300 $26.26 $7,878.00
Disclosure

SEC source: 0001157523-21-001093 · form4.xml · nonDerivative · entry 1

Kortman Kelley · CIK 0001869475 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,800

Read SEC document
August 06, 2021 Filed Aug 6, 2021 20:32 UTC
Viswanathan SubramaniamChief Financial Officer
GrantCommon Stock 51,402 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-001025 · form4.xml · nonDerivative · entry 1

Viswanathan Subramaniam · CIK 0001876812 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,402

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on January 2 of 2022, 2023 and 2024 and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:30 UTC GrantCommon Stock 8,490 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000781 · form4.xml · nonDerivative · entry 2

CREAGH GERARD · CIK 0001413235 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,889

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 10, 2022, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation from service.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:30 UTC GrantCommon Stock 3,049 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000781 · form4.xml · nonDerivative · entry 1

CREAGH GERARD · CIK 0001413235 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,399

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:38 UTC GrantCommon Stock 8,490 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000785 · form4.xml · nonDerivative · entry 1

Reilly John Patrick · CIK 0001310516 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,088

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 10, 2022, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:33 UTC
ABRAMS MARKDirector
GrantCommon Stock 8,490 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000783 · form4.xml · nonDerivative · entry 1

ABRAMS MARK · CIK 0001286122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,828

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 10, 2022, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:36 UTC GrantCommon Stock 19,810 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000784 · form4.xml · nonDerivative · entry 1

Reilly Brian Patrick · CIK 0001784056 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,667

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 10, 2022, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation from service.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 20:30 UTC
STILL DEBRADirector
GrantCommon Stock 8,490 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000782 · form4.xml · nonDerivative · entry 1

STILL DEBRA · CIK 0001733953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,090

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 10, 2022, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
June 10, 2021 Filed Jun 15, 2021 20:32 UTC GrantCommon Stock 8,490 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000794 · form4.xml · nonDerivative · entry 1

Chavers Kevin Gerald · CIK 0001867622 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,490

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) June 10, 2022, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:31 UTC
Yarlagadda ChoudharyDirector · Pres. and Chief Oper. Officer
GrantCommon Stock 50,930 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000216 · form4.xml · nonDerivative · entry 1

Yarlagadda Choudhary · CIK 0001650531 · Director · Pres. and Chief Oper. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,252,752

F1 · kind: Represents shares of Chimera common stock underlying performance share units ("PSUs"), and accrued DERs, that vested on February 16, 2021.

F2 · shares: Each PSU has the economic equivalent of one share of Chimera common stock. The reporting person elected to defer share settlement until separation of service.

F3 · balance_after: Dividend equivalent rights ("DERs") issued on PSUs and restricted stock units ("RSUs") are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:30 UTC
MARRIA MOHITDirector · CEO & Chief Investment Officer
Tax withholdingCommon Stock 8,327 $10.51 $87,516.77
Disclosure

SEC source: 0001157523-21-000214 · form4.xml · nonDerivative · entry 2

MARRIA MOHIT · CIK 0001594020 · Director · CEO & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,011,717

F4 · shares: Shares reported were withheld for payment of taxes associated with the vesting of prior grants of RSUs and PSUs.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:30 UTC
MARRIA MOHITDirector · CEO & Chief Investment Officer
GrantCommon Stock 30,182 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000214 · form4.xml · nonDerivative · entry 1

MARRIA MOHIT · CIK 0001594020 · Director · CEO & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,020,044

F1 · kind: Represents shares of Chimera common stock underlying performance share units ("PSUs"), and accrued DERs, that vested on February 16, 2021.

F2 · shares: Each PSU has the economic equivalent of one share of Chimera common stock. The reporting person elected to defer share settlement until separation of service.

F3 · balance_after: Dividend equivalent rights ("DERs") issued on PSUs and restricted stock units ("RSUs") are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:30 UTC
COLLIGAN ROBERT SChief Financial Officer
Tax withholdingCommon Stock 46,102 $11.94 $550,457.88
Disclosure

SEC source: 0001157523-21-000215 · form4.xml · nonDerivative · entry 2

COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,145

F4 · shares: Shares reported were withheld for payment of taxes associated with the vesting of prior grants of RSUs and PSUs.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:30 UTC
COLLIGAN ROBERT SChief Financial Officer
GrantCommon Stock 28,296 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000215 · form4.xml · nonDerivative · entry 1

COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,247

F1 · kind: Represents shares of Chimera common stock underlying performance share units ("PSUs"), and accrued DERs, that vested on February 16, 2021.

F2 · shares: Each PSU has the economic equivalent of one share of Chimera common stock.

F3 · balance_after: Dividend equivalent rights ("DERs") issued on PSUs and restricted stock units ("RSUs") are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:30 UTC
Kardis Phillip John IIChief Legal Officer
Tax withholdingCommon Stock 25,919 $11.67 $302,474.73
Disclosure

SEC source: 0001157523-21-000213 · form4.xml · nonDerivative · entry 1

Kardis Phillip John II · CIK 0001652530 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,224

F1 · shares: Shares reported were withheld for payment of taxes associated with the vesting of prior grants of restricted stock units.

Read SEC document
January 02, 2021 Filed Jan 5, 2021 21:32 UTC
MARRIA MOHITDirector · CEO & Chief Investment Officer
GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000011 · form4.xml · nonDerivative · entry 2

MARRIA MOHIT · CIK 0001594020 · Director · CEO & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 980,952

F5 · kind: Represents shares of Chimera common stock underlying RSUs. The RSUs are scheduled to vest one-fifth per year on January 15 of each year starting from January 15, 2021 and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · shares: The reporting person elected to defer share settlement until separation of service (such deferred share units are herein referred to as "DSUs").

F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

F4 · balance_after: Dividend equivalent rights ("DERs") issued on RSUs and DSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
January 02, 2021 Filed Jan 5, 2021 21:32 UTC
MARRIA MOHITDirector · CEO & Chief Investment Officer
GrantCommon Stock 47,421 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000011 · form4.xml · nonDerivative · entry 1

MARRIA MOHIT · CIK 0001594020 · Director · CEO & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 480,952

F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · shares: The reporting person elected to defer share settlement until separation of service (such deferred share units are herein referred to as "DSUs").

F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

F4 · balance_after: Dividend equivalent rights ("DERs") issued on RSUs and DSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
January 02, 2021 Filed Jan 5, 2021 21:32 UTC
Yarlagadda ChoudharyDirector · Pres. and Chief Oper. Officer
GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000012 · form4.xml · nonDerivative · entry 2

Yarlagadda Choudhary · CIK 0001650531 · Director · Pres. and Chief Oper. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,182,635

F5 · kind: Represents shares of Chimera common stock underlying RSUs. The RSUs are scheduled to vest one-fifth per year on January 15 of each year starting from January 15, 2021 and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · shares: The reporting person elected to defer share settlement until separation of service (such deferred share units are herein referred to as "DSUs").

F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

F4 · balance_after: Dividend equivalent rights ("DERs") issued on RSUs and DSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
January 02, 2021 Filed Jan 5, 2021 21:32 UTC
Yarlagadda ChoudharyDirector · Pres. and Chief Oper. Officer
GrantCommon Stock 56,336 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000012 · form4.xml · nonDerivative · entry 1

Yarlagadda Choudhary · CIK 0001650531 · Director · Pres. and Chief Oper. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 682,635

F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · shares: The reporting person elected to defer share settlement until separation of service (such deferred share units are herein referred to as "DSUs").

F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

F4 · balance_after: Dividend equivalent rights ("DERs") issued on RSUs and DSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
January 02, 2021 Filed Jan 5, 2021 21:32 UTC
Kardis Phillip John IIChief Legal Officer
GrantCommon Stock 46,947 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000010 · form4.xml · nonDerivative · entry 1

Kardis Phillip John II · CIK 0001652530 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,071

F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · shares: The reporting person elected to defer share settlement until separation of service (such deferred share units are herein referred to as "DSUs").

F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

F4 · balance_after: Dividend equivalent rights ("DERs') issued on RSUs and DSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
January 02, 2021 Filed Jan 5, 2021 21:31 UTC
COLLIGAN ROBERT SChief Financial Officer
GrantCommon Stock 31,298 $0.00 $0.00
Disclosure

SEC source: 0001157523-21-000009 · form4.xml · nonDerivative · entry 1

COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,076

F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

F3 · balance_after: Dividend equivalent rights ("DERs") issued on RSUs and deferred share units are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 16:30 UTC GrantCommon Stock 15,143 $0.00 $0.00
Disclosure

SEC source: 0001157523-20-000859 · form4.xml · nonDerivative · entry 1

Mahoney Dennis · CIK 0001488524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,478

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 1, 2021, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation from service.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 16:22 UTC
DONLIN PAULDirector
GrantCommon Stock 28,078 $0.00 $0.00
Disclosure

SEC source: 0001157523-20-000858 · form4.xml · nonDerivative · entry 1

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,596

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 1, 2021, or (2) the date of the next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until the earlier of (1) January 31, 2036 or (2) separation from service.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:21 UTC GrantCommon Stock 32,179 $0.00 $0.00
Disclosure

SEC source: 0001157523-20-000857 · form4.xml · nonDerivative · entry 1

CREAGH GERARD · CIK 0001413235 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,133

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 1, 2021, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation from service.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:18 UTC
ABRAMS MARKDirector
GrantCommon Stock 15,143 $0.00 $0.00
Disclosure

SEC source: 0001157523-20-000856 · form4.xml · nonDerivative · entry 1

ABRAMS MARK · CIK 0001286122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,646

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 1, 2021, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:37 UTC GrantCommon Stock 15,143 $0.00 $0.00
Disclosure

SEC source: 0001157523-20-000860 · form4.xml · nonDerivative · entry 1

Reilly John Patrick · CIK 0001310516 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,358

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 1, 2021, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:18 UTC
STILL DEBRADirector
GrantCommon Stock 15,143 $0.00 $0.00
Disclosure

SEC source: 0001157523-20-000855 · form4.xml · nonDerivative · entry 1

STILL DEBRA · CIK 0001733953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,679

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 1, 2021, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:15 UTC GrantCommon Stock 15,143 $0.00 $0.00
Disclosure

SEC source: 0001157523-20-000853 · form4.xml · nonDerivative · entry 1

BAZEMORE TERESA BRYCE · CIK 0001721267 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,083

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 1, 2021, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation from service.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:15 UTC GrantCommon Stock 35,334 $0.00 $0.00
Disclosure

SEC source: 0001157523-20-000852 · form4.xml · nonDerivative · entry 1

Reilly Brian Patrick · CIK 0001784056 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,015

F1 · shares: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 1, 2021, or (2) the date of the Company's next annual stockholder's meeting, and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until the earlier of (1) January 31, 2025 or (2) separation from service.

Read SEC document
March 18, 2020 Filed Mar 18, 2020 12:46 UTC
LAMBIASE MATTHEWDirector · CEO, President and Director
GrantCommon Stock 50,000 $8.51 $425,500.00
Disclosure

SEC source: 0001157523-20-000373 · form4.xml · nonDerivative · entry 1

LAMBIASE MATTHEW · CIK 0001419165 · Director · CEO, President and Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 993,876

Read SEC document
March 18, 2020 Filed Mar 18, 2020 21:44 UTC
DONLIN PAULDirector
GrantSeries D Preferred Stock 7,400 $8.41 $62,234.00
Disclosure

SEC source: 0001157523-20-000377 · form4.xml · nonDerivative · entry 8

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By - Donlin Financial LLC

Disclosed balance after: 8,100

Read SEC document
March 18, 2020 Filed Mar 18, 2020 21:44 UTC
DONLIN PAULDirector
GrantSeries C Preferred Stock 5,475 $6.96 $38,106.00
Disclosure

SEC source: 0001157523-20-000377 · form4.xml · nonDerivative · entry 7

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By - Donlin Financial LLC

Disclosed balance after: 9,323

Read SEC document
March 18, 2020 Filed Mar 18, 2020 21:44 UTC
DONLIN PAULDirector
GrantSeries B Preferred Stock 8,400 $7.95 $66,780.00
Disclosure

SEC source: 0001157523-20-000377 · form4.xml · nonDerivative · entry 6

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By - Donlin Financial LLC

Disclosed balance after: 20,481

Read SEC document
March 18, 2020 Filed Mar 18, 2020 21:44 UTC
DONLIN PAULDirector
GrantCommon Stock 65,000 $8.09 $525,850.00
Disclosure

SEC source: 0001157523-20-000377 · form4.xml · nonDerivative · entry 5

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By - Donlin Financial LLC

Disclosed balance after: 320,609

F1 · ownership.nature: Mr. Donlin is the managing member of Donlin Financial LLC and retains a 2% ownership interest. The remaining interests are owned by a grantor trust for the benefit of his children.

Read SEC document
March 18, 2020 Filed Mar 18, 2020 21:44 UTC
DONLIN PAULDirector
GrantSeries D Preferred Stock 3,750 $7.87 $29,512.50
Disclosure

SEC source: 0001157523-20-000377 · form4.xml · nonDerivative · entry 4

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Read SEC document
March 18, 2020 Filed Mar 18, 2020 21:44 UTC
DONLIN PAULDirector
GrantSeries C Preferred Stock 2,358 $6.64 $15,657.12
Disclosure

SEC source: 0001157523-20-000377 · form4.xml · nonDerivative · entry 3

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,366

Read SEC document
March 18, 2020 Filed Mar 18, 2020 21:44 UTC
DONLIN PAULDirector
GrantSeries B Preferred Stock 1,100 $8.33 $9,163.00
Disclosure

SEC source: 0001157523-20-000377 · form4.xml · nonDerivative · entry 2

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,699

Read SEC document
March 18, 2020 Filed Mar 18, 2020 21:44 UTC
DONLIN PAULDirector
GrantCommon Stock 10,000 $6.62 $66,200.00
Disclosure

SEC source: 0001157523-20-000377 · form4.xml · nonDerivative · entry 1

DONLIN PAUL · CIK 0001418488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,002

Read SEC document
March 18, 2020 Filed Mar 18, 2020 23:04 UTC GrantCommon Stock 36,000 $8.44 $303,840.00
Disclosure

SEC source: 0001157523-20-000375 · form4.xml · nonDerivative · entry 1

CREAGH GERARD · CIK 0001413235 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,637

Read SEC document
March 18, 2020 Filed Mar 19, 2020 00:20 UTC
Yarlagadda ChoudharyChief Operating Officer
GrantCommon Stock 40,600 $7.50 $304,500.00
Disclosure

SEC source: 0001157523-20-000376 · form4.xml · nonDerivative · entry 2

Yarlagadda Choudhary · CIK 0001650531 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 366,287

F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
March 18, 2020 Filed Mar 19, 2020 00:20 UTC
Yarlagadda ChoudharyChief Operating Officer
GrantCommon Stock 300 $6.90 $2,070.00
Disclosure

SEC source: 0001157523-20-000376 · form4.xml · nonDerivative · entry 1

Yarlagadda Choudhary · CIK 0001650531 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 554,288

Read SEC document
March 18, 2020 Filed Mar 18, 2020 16:19 UTC
MARRIA MOHITChief Investment Officer
GrantCommon Stock 3,125 $7.81 $24,406.25
Disclosure

SEC source: 0001157523-20-000372 · form4.xml · nonDerivative · entry 4

MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Sana Marria

Disclosed balance after: 3,125

F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
March 18, 2020 Filed Mar 18, 2020 16:19 UTC
MARRIA MOHITChief Investment Officer
GrantCommon Stock 3,125 $7.82 $24,437.50
Disclosure

SEC source: 0001157523-20-000372 · form4.xml · nonDerivative · entry 3

MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ish Marria

Disclosed balance after: 3,125

F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
March 18, 2020 Filed Mar 18, 2020 16:19 UTC
MARRIA MOHITChief Investment Officer
GrantCommon Stock 14,000 $9.25 $129,500.00
Disclosure

SEC source: 0001157523-20-000372 · form4.xml · nonDerivative · entry 2

MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 43,236

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.